Autoimmune Hemolytic Anemia After mRNA COVID Vaccine

Zainab Fatima; Blair R A Reece; J Suzanne Moore; Robert T Means Jr

doi:10.1177/23247096211073258

Autoimmune Hemolytic Anemia After mRNA COVID Vaccine

J Investig Med High Impact Case Rep. 2022 Jan-Dec:10:23247096211073258. doi: 10.1177/23247096211073258.

Authors

Zainab Fatima¹, Blair R A Reece¹, J Suzanne Moore¹, Robert T Means Jr¹

Affiliation

¹ East Tennessee State University, Johnson City, USA.

Abstract

Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.

Keywords: COVID; COVID vaccine; autoimmune hemolytic anemia; hematology oncology; hemolysis; rheumatology.

Publication types

Case Reports

MeSH terms

Anemia, Hemolytic, Autoimmune* / chemically induced
COVID-19 Vaccines
COVID-19*
Humans
RNA, Messenger / genetics
SARS-CoV-2
Vaccines*

Substances

COVID-19 Vaccines
RNA, Messenger
Vaccines